The combination of GLP-1 therapy and renal impairment warrants closer monitoring, though these medications are generally considered safe in moderate kidney disease and some agents have shown potential renal protective benefits in clinical trials
Restarting After a Break If you previously took tirzepatide and stopped, then decide to restart, youll typically begin again at 2.5 mg and work back up through the schedule
September 1, 2025: FDA Approves Wegovy for Fatty Liver Disease The FDA has granted a new indication for Wegovy (semaglutide) to treat metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease in adults with moderate to advanced fibrosis
Possible Causes of Dizziness with Wegovy While its possible for people to experience dizziness with any GLP-1 medicationthe Ozempic package insert reports that less than 0.4% of users experienced fatigue, dysgeusia (altered taste)dizziness appears to be more commonly associated with Wegovy use
Results vary depending on dose, duration, and lifestyle habits
